Skip to main content

Login to North West London Pathology – consumables service

If you need a new account or you have a query about your order, please telephone the pathology call centre on 0203 313 5353.

If you have forgotten your password you can reset this yourself. Please click here if you have forgotten your password.

Results Line and Enquiries

0203 313 5353

ApoE genotyping

Category Specialist Integrated Haematological Malignancy Diagnostic Service (SIHMDS) >> Molecular Pathology
Test background

Apolipoprotein E (ApoE) has a pivotal role in the metabolism of VLDL-cholesterol, and HDL-cholesterol, and as a ligand, it binds both LDL-cholesterol and ApoE receptors. The APOE gene is located on chromosome 19q13.2 and has 3 main allelic variants: ε3, ε4, andε2. ε3 is the most common, followed by ε4 and ε2. These 3 allelic variants differ at 2 single-base variations located in exon 4 at codon positions 130 and 176 (Historically described as positions 112 and 158).

The single nucleotide changes of APOE c.388T>C p.(Cys130Arg) (112T>C) (SNP: rs429358) and APOE c.526C>T p.(Arg176Cys) (158C>T) (SNP: rs7412) encode Cys and Arg, respectively. ε2 has a T at both positions 112 and 158; ε3 has one T and one C at either position 112 and 158;and ε4 has a C at both positions.

These isoforms have been widely studied as possible risk factors for coronary heart disease, type III hyperlipoproteinaemia and strokes.

A real time fluorescence PCR genotyping assay is used to determine the presence of the APOE 112T>C and 158C>T variants and haplotype.

Click here to download the SIHMDS request form

Clinical Indications

For prognostic testing in coronary heart disease, type III hyperlipoproteinaemia and strokes.

Sample & container required 4ml Peripheral Blood in EDTA (lavender/purple top)
Turnaround time 14 calendar days

The laboratory is not UKAS accredited for this test.